18F-FDG PET/CT imaging in rectal cancer: relationship with theRASmutational status
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
18F-FDG PET/CT imaging in rectal cancer: relationship with theRASmutational status
Authors
Keywords
-
Journal
BRITISH JOURNAL OF RADIOLOGY
Volume 89, Issue 1063, Pages 20160212
Publisher
British Institute of Radiology
Online
2016-05-05
DOI
10.1259/bjr.20160212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDG Uptake in Non–Small Cell Lung Cancer Is Not an Independent Predictor of EGFR or KRAS Mutation Status
- (2015) Seok Mo Lee et al. CLINICAL NUCLEAR MEDICINE
- Metabolic Phenotype of Stage IV Lung Adenocarcinoma
- (2015) Elaine Yuen Phin Lee et al. CLINICAL NUCLEAR MEDICINE
- Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials
- (2015) M. Peeters et al. EUROPEAN JOURNAL OF CANCER
- Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [18F]FDG PET/CT scans in locally advanced rectal cancer
- (2015) Ji-In Bang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Texture Analysis as Imaging Biomarker of Tumoral Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients Studied with 3-T Magnetic Resonance
- (2015) Carlo N. De Cecco et al. INVESTIGATIVE RADIOLOGY
- Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An 18F-FDG PET Study
- (2015) J. Nagarajah et al. JOURNAL OF NUCLEAR MEDICINE
- Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer
- (2015) K. Kawada et al. JOURNAL OF NUCLEAR MEDICINE
- Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer
- (2015) Seokho Yoon et al. MEDICINE
- Concordant analysis of KRAS, BRAF, PIK3CA mutations and PTEN expression between primary colorectal cancer and matched metastases
- (2015) Chen Mao et al. Scientific Reports
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mutational analysis and clinical correlation of metastatic colorectal cancer
- (2014) Andrea L. Russo et al. CANCER
- Correlation Between PET/CT Parameters and KRAS Expression in Colorectal Cancer
- (2014) Shang-Wen Chen et al. CLINICAL NUCLEAR MEDICINE
- Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
- (2014) Carlos Caicedo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi-Cancer Site Patient Cohort
- (2014) M. Hatt et al. JOURNAL OF NUCLEAR MEDICINE
- Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
- (2014) R. A. Bundschuh et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
- (2013) Soo Jung Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical significance of VEGFR-2 and 18F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy
- (2013) Claudio V. Sole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma
- (2013) Mathieu Hatt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma
- (2013) N.-M. Cheng et al. JOURNAL OF NUCLEAR MEDICINE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer
- (2012) K. Kawada et al. CLINICAL CANCER RESEARCH
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
- (2012) Mai Yamauchi et al. GUT
- Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET
- (2012) F. Tixier et al. JOURNAL OF NUCLEAR MEDICINE
- Are Pretreatment 18F-FDG PET Tumor Textural Features in Non-Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
- (2012) G. J. R. Cook et al. JOURNAL OF NUCLEAR MEDICINE
- PET functional volume delineation: a robustness and repeatability study
- (2011) Mathieu Hatt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
- (2011) F. Tixier et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non-Small Cell Lung Cancer Tumor Delineation
- (2011) M. Hatt et al. JOURNAL OF NUCLEAR MEDICINE
- Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
- (2011) R. H. Mak et al. ONCOLOGIST
- Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer
- (2010) A. A. Martoni et al. ANNALS OF ONCOLOGY
- Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
- (2010) Li-Xin Qiu et al. EUROPEAN JOURNAL OF CANCER
- Accurate Automatic Delineation of Heterogeneous Functional Volumes in Positron Emission Tomography for Oncology Applications
- (2010) Mathieu Hatt et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
- (2009) F Loupakis et al. BRITISH JOURNAL OF CANCER
- 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis
- (2009) Im Il Na et al. LUNG CANCER
- Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma
- (2009) Chun-Ta Huang et al. MEDICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coregistered FDG PET/CT-Based Textural Characterization of Head and Neck Cancer for Radiation Treatment Planning
- (2008) Huan Yu et al. IEEE TRANSACTIONS ON MEDICAL IMAGING
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
- (2008) Astrid Lièvre et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now